These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 7047834)

  • 21. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of glucocorticoid action on murine natural killer cell activity.
    Cox WI; Holbrook NJ; Friedman H
    J Natl Cancer Inst; 1983 Nov; 71(5):973-81. PubMed ID: 6580499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of antibodies to IL-2 receptor and Asialo GM1 on graft-versus-leukemia effects induced by bone marrow allografts in murine B cell leukemia.
    Weiss L; Reich S; Slavin S
    Bone Marrow Transplant; 1995 Sep; 16(3):457-61. PubMed ID: 8535320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The NK-1.1(-) mouse: a model to study differentiation of murine NK cells.
    Koo GC; Dumont FJ; Tutt M; Hackett J; Kumar V
    J Immunol; 1986 Dec; 137(12):3742-7. PubMed ID: 3782794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
    J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens.
    Cohen P; Vourka-Karussis U; Weiss L; Slavin S
    J Immunol; 1993 Nov; 151(9):4803-10. PubMed ID: 8409438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The abrogation of in vivo resistance to parental bone marrow transplantation and of in vitro natural cell-mediated cytotoxicity to the YAC lymphoma by in vivo growth of a transformed thymus-derived cell culture.
    Gardner FH; Gallagher MT; Datta SK; Trentin JJ
    Exp Hematol; 1980 Sep; 8(8):1040-7. PubMed ID: 7009189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Joint influence of natural killers (NK) and hemopoietic stroma on rejection of parent stem cells.
    Pirozhkov A; Dozmorov I; Petrov R
    Bone Marrow Transplant; 1995 Nov; 16(5):683-93. PubMed ID: 8547866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of graft-versus-leukemia (GVL) activity in murine leukemia models after IL-2 pretreatment of syngeneic and allogeneic bone marrow grafts.
    Zeis M; Uharek L; Glass B; Gaska T; Gassmann W; Mueller-Ruchholtz W
    Bone Marrow Transplant; 1994 Nov; 14(5):711-5. PubMed ID: 7889004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Life history of cells mediating natural resistance to tumor cells and bone-marrow transplants: the respective roles of cell lineage commitment and host environment in determining strain characteristics of natural resistance to foreign marrow grafts.
    Miller SC
    Am J Anat; 1984 Jul; 170(3):367-76. PubMed ID: 6383004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OK-432 stimulates primary production and activity of murine natural killer cells.
    Pollack SB
    Nat Immun Cell Growth Regul; 1987; 6(5):224-36. PubMed ID: 3444437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of alloreactive natural killer cell in mouse MHC haploidentical bone marrow transplantation].
    He Y; Wang HH; Wang M; Zhou Z; Zhai WJ; Huang Y; Jiang EL; Wang ZD; Zhou SY; Liu QG; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):82-6. PubMed ID: 16732957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stages in the development of radiation-induced thymic lymphomas in C57 BL/Ka mice: preleukemic cells become progressively resistant to the tumor preventing effects of a bone marrow graft.
    Humblet C; Greimers R; Boniver J; Defrense MP
    Exp Hematol; 1997 Feb; 25(2):109-13. PubMed ID: 9015210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The primary role of murine bone marrow in the production of natural killer cells. A cytokinetic study.
    Pollack SB; Rosse C
    J Immunol; 1987 Oct; 139(7):2149-56. PubMed ID: 3655362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetics, regulation, and specificity of murine natural antitumor antibodies and natural killer cells.
    Chow DA; Wolosin LB; Greenberg AH
    J Natl Cancer Inst; 1981 Aug; 67(2):445-53. PubMed ID: 6943381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The in vivo effects of steel factor on natural killer lineage cells in murine spleen and bone marrow.
    Miller SC; Fleming WH; Zsebo KM; Weissman IL
    Nat Immun; 1993; 12(6):293-301. PubMed ID: 7505667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parallelism between the effect of cortisone acetate on hybrid resistance and natural killing.
    Lotzová E; Savary CA
    Exp Hematol; 1981 Aug; 9(7):766-74. PubMed ID: 7032960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of loss of natural killer activity in P815 ascites tumor bearing DBA/2 mice.
    Saxena RK; Saxena QB; Adler WH
    Nat Immun Cell Growth Regul; 1983-1984; 3(1):34-42. PubMed ID: 6235448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
    Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
    Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.